A Pilot Study Using a Collagen/Oxidized Regenerative Cellulose Dressing for Split- Thickness Skin Graft Donor Sites to Reduce Pain and Bleeding Complications.

IF 1 4区 医学 Q4 DERMATOLOGY Wound management & prevention Pub Date : 2022-12-01 DOI:10.25270/wmp.2022.12.2024
Emily Alberto, R. Caplan, J. Getchell, Luis Cardenas, Kathy E Gallagher
{"title":"A Pilot Study Using a Collagen/Oxidized Regenerative Cellulose Dressing for Split- Thickness Skin Graft Donor Sites to Reduce Pain and Bleeding Complications.","authors":"Emily Alberto, R. Caplan, J. Getchell, Luis Cardenas, Kathy E Gallagher","doi":"10.25270/wmp.2022.12.2024","DOIUrl":null,"url":null,"abstract":"BACKGROUND\nStandardized treatment of split-thickness skin graft (STSG) donor sites is not established. Bleeding can necessitate premature dressing changes, interrupting the healing process and increasing pain.\n\n\nPURPOSE\nA collagen/oxidized regenerated cellulose (C/ORC) dressing was used on the donor site. The authors hypothesized that the collagen matrix could decrease bleeding-related complications, reduce pain, and foster epithelialization.\n\n\nMETHODS\nThe C/ORC matrix was applied to the donor site after hemostasis was achieved. Dressings were removed between postoperative days 4 and 7, and the patients' pain levels, bleeding complications, and percentage healed were recorded.\n\n\nRESULTS\nThirty-nine patients were treated with the C/ORC donor site dressing. Of these, 35 patients (89.7%) were receiving at least prophylactic anticoagulation, and no bleeding complications were recorded. The average area of donor sites was 123.8 cm2 (range, 20-528 cm2). Utilizing the Numerical Rating Scale, 25 patients (64.1%) reported no pain with dressing removal while 5 (12.8%) reported a decrease in pain. The percentage of epithelialization as assessed by treating clinician was at least equivalent to other modalities.\n\n\nCONCLUSIONS\nThe application of a C/ORC matrix to STSG donor wound sites resulted in no bleeding complications and excellent pain control while promoting epithelialization in the patients studied. Following this study, the C/ORC dressing has been incorporated into the authors' standard protocol.","PeriodicalId":23741,"journal":{"name":"Wound management & prevention","volume":null,"pages":null},"PeriodicalIF":1.0000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Wound management & prevention","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.25270/wmp.2022.12.2024","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

BACKGROUND Standardized treatment of split-thickness skin graft (STSG) donor sites is not established. Bleeding can necessitate premature dressing changes, interrupting the healing process and increasing pain. PURPOSE A collagen/oxidized regenerated cellulose (C/ORC) dressing was used on the donor site. The authors hypothesized that the collagen matrix could decrease bleeding-related complications, reduce pain, and foster epithelialization. METHODS The C/ORC matrix was applied to the donor site after hemostasis was achieved. Dressings were removed between postoperative days 4 and 7, and the patients' pain levels, bleeding complications, and percentage healed were recorded. RESULTS Thirty-nine patients were treated with the C/ORC donor site dressing. Of these, 35 patients (89.7%) were receiving at least prophylactic anticoagulation, and no bleeding complications were recorded. The average area of donor sites was 123.8 cm2 (range, 20-528 cm2). Utilizing the Numerical Rating Scale, 25 patients (64.1%) reported no pain with dressing removal while 5 (12.8%) reported a decrease in pain. The percentage of epithelialization as assessed by treating clinician was at least equivalent to other modalities. CONCLUSIONS The application of a C/ORC matrix to STSG donor wound sites resulted in no bleeding complications and excellent pain control while promoting epithelialization in the patients studied. Following this study, the C/ORC dressing has been incorporated into the authors' standard protocol.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
一项使用胶原蛋白/氧化再生纤维素敷料用于中厚皮肤移植供体部位以减少疼痛和出血并发症的初步研究。
背景:尚未建立对中厚皮片(STSG)供区的标准化治疗。出血可能需要提前更换敷料,从而中断愈合过程并增加疼痛。在供体部位使用PURPOSEA胶原/氧化再生纤维素(C/ORC)敷料。作者假设胶原基质可以减少出血相关并发症,减轻疼痛,促进上皮化。方法止血后,将C/ORC基质应用于供区。在术后第4天至第7天期间去除敷料,并记录患者的疼痛程度、出血并发症和治愈率。结果9例患者均采用C/ORC供区敷料进行治疗。其中,35名患者(89.7%)至少接受了预防性抗凝治疗,无出血并发症记录。供体部位的平均面积为123.8cm2(范围为20-528cm2)。使用数字评定量表,25名患者(64.1%)报告脱药后没有疼痛,5名患者(12.8%)报告疼痛减轻。治疗临床医生评估的上皮化百分比至少与其他模式相当。结论:在所研究的患者中,将C/ORC基质应用于STSG供体伤口部位,在促进上皮化的同时,没有出现出血并发症和良好的疼痛控制。在这项研究之后,C/ORC敷料已纳入作者的标准方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Wound management & prevention
Wound management & prevention Nursing-Medical and Surgical Nursing
CiteScore
1.70
自引率
8.30%
发文量
41
期刊介绍: Information not localized
期刊最新文献
A case series describing combined negative pressure wound therapy and split-thickness skin graft as a method of sterilizing and closing midline laparotomy wounds near ostomies. A new decision tool to objectively select the most appropriate ostomy system - a survey among ostomy nurse specialists. A review of the current trends in chronic wound and scar management. Comparative occipital pressure mapping in the operating room. Early postoperative complications of elective versus emergency stoma creation: a tertiary academic center experience.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1